Yongjun Piao
Overview
Explore the profile of Yongjun Piao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang S, Chen Y, Jia T, Chang Y, Li W, Piao Y, et al.
Int J Gynaecol Obstet
. 2024 Aug;
168(2):701-708.
PMID: 39189090
Objective: To develop a model based on maternal serum liquid chromatography tandem mass spectrometry (LC-MS/MS) proteins to predict spontaneous preterm birth (sPTB). Methods: This nested case-control study used the data...
2.
Wang Z, Liu X, Ni J, Qi Y, Song Z, Piao Y
Acta Derm Venereol
. 2024 Aug;
104:adv40162.
PMID: 39188088
No abstract available.
3.
Guan R, Lin Y, Zhang C, Wang Z, Wu Z, Liu X, et al.
Arch Dermatol Res
. 2024 Jul;
316(7):483.
PMID: 39042154
Severe alopecia areata (AA) is a nonscarring hair loss for immune disorder and SALT score ≥ 50%. The guidelines for managing patients with severe AA suggest treatments: systemic steroids, JAK...
4.
Chen S, Liu Y, Chen X, Tao H, Piao Y, Huang H, et al.
Cell Prolif
. 2024 May;
57(11):e13679.
PMID: 38801100
Uncovering mechanisms of endogenous regeneration and repair through resident stem cell activation will allow us to develop specific therapies for injuries and diseases by targeting resident stem cell lineages. Sox9...
5.
Wang Z, Li T, Gong L, Song Z, Piao Y
Int J Dermatol
. 2024 May;
63(10):1444-1446.
PMID: 38727093
No abstract available.
6.
Li T, Shi J, Wang L, Qin X, Zhou R, Dong M, et al.
MedComm (2020)
. 2023 Sep;
4(5):e355.
PMID: 37655051
Immune checkpoint blockades are the most promising therapy in lung adenocarcinoma (LUAD). However, the response rate remains limited, underscoring the urgent need for effective sensitizers. Interleukin 4 induced 1 (IL4I1)...
7.
Li N, Xu W, Liu H, Zhou R, Zou S, Wang S, et al.
Front Genet
. 2023 Apr;
14:1154067.
PMID: 37065482
Diminished ovarian reserve is one of the most important causes of female infertility. In the etiology study of DOR, besides age, it is known that chromosomal abnormality, radiotherapy, chemotherapy and...
8.
Yang Y, Xu X, Xie Y, Liu Y, Ning C, Ai Y, et al.
Curr Pharm Des
. 2022 Jun;
28(26):2189-2202.
PMID: 35718975
Background: Glioma is the most common malignant intracranial tumor with high lethality. Despite surgery combined with chemoradiotherapy, the prognosis for patients with glioma remains poor. This is primarily due to...
9.
Wang L, Piao Y, Zhang D, Feng W, Wang C, Cui X, et al.
Stem Cell Res Ther
. 2022 Jun;
13(1):245.
PMID: 35690796
Background: The ubiquitin-proteasome system plays important roles in maintaining the self-renewal and differentiation of stem and progenitor cells through highly ordered degradation of cellular proteins. Fbxw11, an E3 ligase, participates...
10.
Li S, Zhang G, Lu Y, Zhao T, Gao C, Liu W, et al.
Front Oncol
. 2022 Mar;
12:841819.
PMID: 35265528
Objective: Some patients with pancreatic ductal adenocarcinoma (PDAC) are prone to rapid recurrence or metastasis after radical resection. However, evaluation methods for effectively identifying these patients are lacking. In this...